Dermatologic look- or sound-alike medications.

Area of Science:

• Dermatology
• Pharmacology
• Patient Safety

Background:

• Medication errors significantly impact patient outcomes, leading to injury and death.
• Approximately 25% of medication errors stem from similar-sounding or looking drug names.
• Confusing drug nomenclature poses a specific risk within dermatology practice.

Purpose of the Study:

• To increase awareness among dermatologists and healthcare professionals regarding confusing dermatologic drug names.
• To provide a comprehensive list of look-alike and sound-alike drug names relevant to dermatology.
• To propose strategies for reducing medication errors associated with drug nomenclature in dermatology.

Main Methods:

• Literature review and compilation of dermatologic drug names.
• Identification and categorization of drug names with look-alike and sound-alike properties.
• Development of a table listing 166 confusing drug name pairs.

Main Results:

• A table of 166 look-alike and sound-alike dermatologic drug names was created.
• The study highlights the prevalence of nomenclature-related medication errors in dermatology.
• Identified drug names pose a risk for confusion and potential patient harm.

Conclusions:

• Heightened awareness of confusing drug names is crucial for dermatologists.
• Implementing measures to address drug nomenclature issues can enhance patient safety.
• Reducing medication errors related to drug names is essential for optimal dermatologic care.